{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:56:30Z","timestamp":1779216990840,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01806","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T09:10:50Z","timestamp":1602148250000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72\/AS01E and MVA85A"],"prefix":"10.3389","volume":"11","author":[{"given":"Inayat","family":"Ullah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheen","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijaz","family":"Ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Safia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kifayat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"B1","volume-title":"Substance Abuse Department, World Health Organization. Department of Mental Health, Substance Abuse. Global status report on alcohol 2004","year":"2019"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.280.6210.293-a","article-title":"Diet and ulcerative colitis","volume":"280","author":"Thornton","year":"1980","journal-title":"Br Med J."},{"key":"B3","first-page":"276","article-title":"Tuberculosis studies in Muscogee County, Georgia. twenty-year evaluation of a community trial of BCG vaccination","volume":"91","author":"Comstock","year":"1976","journal-title":"Public Health Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccines."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human t-cell responses to a member of a novel Mycobacterium tuberculosis mtb39Gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infect Immun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","article-title":"A randomized, controlled dose-finding phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/QAD.0000000000000343","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I\/II, randomized trial","volume":"28","author":"Thacher","year":"2014","journal-title":"AIDS."},{"key":"B15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tube.2014.07.001","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial","volume":"94","author":"Idoko","year":"2014","journal-title":"Tuberculosis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e5353","DOI":"10.1097\/MD.0000000000005353","article-title":"Effect of vitamin D3 on self-perceived fatigue: a double-blind randomized placebo-controlled trial","volume":"95","author":"Nowak","year":"2016","journal-title":"Medicine."},{"key":"B17","author":"PIC","year":"2011","journal-title":"University Faculty Details Page on DU Web-Site."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"van Der Meeren","year":"2018","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1128\/JVI.00246-12","article-title":"Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques","volume":"86","author":"Garber","year":"2012","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/infdis\/jir195","article-title":"Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants","volume":"203","author":"Scriba","year":"2011","journal-title":"J Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in mycobacterium tuberculosis\u2013infected individuals","volume":"179","author":"Sander","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"B26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1371\/journal.pone.0001052","article-title":"Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials","volume":"2","author":"Pathan","year":"2007","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e000223","DOI":"10.1136\/bmjopen-2011-000223","article-title":"A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults","volume":"1","author":"Minassian","year":"2011","journal-title":"BMJ Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1016\/j.vaccine.2012.06.084","article-title":"Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults","volume":"30","author":"Pathan","year":"2012","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2459","DOI":"10.1097\/MD.0000000000002459","article-title":"A randomized, controlled safety, and immunogenicity trial of the M72\/AS01 candidate tuberculosis vaccine in HIV-positive Indian adults","volume":"95","author":"Kumarasamy","year":"2016","journal-title":"Medicine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tube.2012.10.011","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02 in PPD positive adults: a randomized controlled phase I\/II study","volume":"93","author":"Spertini","year":"2013","journal-title":"Tuberculosis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijmyco.2015.12.001","article-title":"Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization","volume":"5","author":"Velayati","year":"2016","journal-title":"Int J Mycobacteriol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12026-011-8229-7","article-title":"Latent tuberculosis: what the host \u201csees\u201d?","volume":"50","author":"Gideon","year":"2011","journal-title":"Immunol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"iv24","DOI":"10.1136\/ard.2005.042531","article-title":"Immunological control of tuberculosis: role of tumour necrosis factor and more","volume":"64","author":"Stenger","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cyto.2008.05.002","article-title":"Mycobacterium tuberculosis-specific CD4+, IFN\u03b3+, and TNF\u03b1+ multifunctional memory T cells coexpress GM-CSF","volume":"43","author":"Mueller","year":"2008","journal-title":"Cytokine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.4049\/jimmunol.0901563","article-title":"RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium","volume":"183","author":"Knoop","year":"2009","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.4049\/jimmunol.1103474","article-title":"NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-\u03b3 and perforin-dependent mechanisms","volume":"189","author":"Ge","year":"2012","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-065X.2010.00997.x","article-title":"Views of immunology: effector T cells","volume":"240","author":"Lewinsohn","year":"2011","journal-title":"Immunol Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/srep01809","article-title":"Prominent role for T cell-derived tumour necrosis factor for sustained control of mycobacterium tuberculosis infection","volume":"3","author":"Quesniaux","year":"2013","journal-title":"Sci Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediat Inflamm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH 1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fimmu.2018.00564","article-title":"Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72\/AS01 in bacillus Calmette\u2013Gu\u00e9rin-vaccinated adults","volume":"9","author":"van Den Berg","year":"2018","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tube.2006.01.008","article-title":"The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy","volume":"86","author":"Glatman-Freedman","year":"2006","journal-title":"Tuberculosis (Edinb)."},{"key":"B54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ajpath.2012.05.009","article-title":"Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis","volume":"181","author":"Phuah","year":"2012","journal-title":"Am J Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13120","DOI":"10.1097\/MD.0000000000013120","article-title":"Long-term safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in HIV-positive and-negative Indian adults: results from a phase II randomized controlled trial","volume":"97","author":"Kumarasamy","year":"2018","journal-title":"Medicine."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine."},{"key":"B58","first-page":"481","article-title":"Encouraging families to move from poor neighbourhoods reduces obesity","volume":"29","author":"Farham","year":"2011","journal-title":"Cont Med Educ."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"3","author":"Agnandji","year":"2012","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fimmu.2017.01008","article-title":"RTS, S\/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric african phase III trial","volume":"8","author":"Moncunill","year":"2017","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0264-410X(94)80052-2","article-title":"Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma","volume":"12","author":"Livingston","year":"1994","journal-title":"Vaccine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"88ra56","DOI":"10.1126\/scitranslmed.3002461","article-title":"Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants","volume":"3","author":"Ota","year":"2011","journal-title":"Sci Transl Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T09:10:53Z","timestamp":1602148253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2020.01806"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01806","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"article-number":"1806"}}